Government Affairs Consulting Firm.
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2026 | UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA) |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$30,000 | — | |
| 2026 | SANOFI U.S. SERVICES, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2026 | PHLOW CORP. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2026 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | — | |
| 2026 | PAPERBIRCH STRATEGIES ON BEHALF OF AP3 BIOMEDICAL |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | — | |
| 2026 | OTSUKA AMERICA PHARMACEUTICAL, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2026 | MERCK & CO., INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$50,000 | — | |
| 2026 | MEDTRONIC, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$40,000 | — | |
| 2026 | JUUL LABS INC |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$60,000 | — | |
| 2026 | IPSEN BIOPHARMACEUTICALS, INC. |
2nd Quarter (Apr 1 - June 30) 2nd Quarter - Report |
$20,000 | — |
| Client | Filings | Total Income |
|---|---|---|
| ABBOTT LABORATORIES | 66 | $3,200,000 |
| GLAXOSMITHKLINE | 66 | $2,520,000 |
| UNITED SERVICES AUTOMOBILE ASSOCIATION (USAA) | 66 | $1,640,000 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 65 | $3,840,000 |
| MEDTRONIC, INC. | 65 | $2,480,000 |
| CALIFORNIA LIFE SCIENCES | 65 | $2,100,000 |
| ABBVIE INC. | 56 | $2,680,000 |
| ASTRAZENECA PHARMACEUTICALS LP | 51 | $2,960,000 |
| ALEXION PHARMACEUTICALS | 50 | $2,530,000 |
| ENOVIS | 50 | $2,020,000 |
| 23ANDME, INC. | 50 | $1,150,000 |
| JUUL LABS INC | 38 | $1,940,000 |
| SANOFI U.S. SERVICES, INC. | 37 | $1,770,000 |
| IPSEN BIOPHARMACEUTICALS, INC. | 37 | $1,000,000 |
| CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 36 | $1,050,000 |
| BIOGEN | 35 | $1,700,000 |
| MERCK & CO., INC. | 35 | $1,700,000 |
| SUPERNUS PHARMACEUTICALS FKA SAGE THERAPEUTICS | 33 | $1,580,000 |
| GILEAD SCIENCES, INC. | 31 | $1,800,000 |
| INCYTE CORPORATION | 29 | $1,470,000 |
| Name | Disclosed Prior Position |
|---|---|
| DARREN WILLCOX | House Rules Comm Assoc, Subcomm Staff Dir. |